Cargando…
TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis
BACKGROUND: The aim of this study was to examine BRF2 expression in patients with non-small cell lung cancer (NSCLC) and explore the relationship of BRF2 protein with clinicopathologic factors, tumor angiogenesis and prognosis. METHODS: Both BRF2 protein and intratumoral microvessels were examined b...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921153/ https://www.ncbi.nlm.nih.gov/pubmed/24523874 http://dx.doi.org/10.1371/journal.pone.0088032 |
_version_ | 1782303274413588480 |
---|---|
author | Lu, Ming Tian, Hui Yue, Weiming Li, Lin Li, Shuhai Qi, Lei Hu, Wensi Gao, Cun Si, Libo |
author_facet | Lu, Ming Tian, Hui Yue, Weiming Li, Lin Li, Shuhai Qi, Lei Hu, Wensi Gao, Cun Si, Libo |
author_sort | Lu, Ming |
collection | PubMed |
description | BACKGROUND: The aim of this study was to examine BRF2 expression in patients with non-small cell lung cancer (NSCLC) and explore the relationship of BRF2 protein with clinicopathologic factors, tumor angiogenesis and prognosis. METHODS: Both BRF2 protein and intratumoral microvessels were examined by immunohistochemical staining in 107 non-small cell lung cancer patients. Intratumoral m icrovessel density (MVD) was measured by counting CD-34 positive immunostained endothelial cells. Western blot and RT-PCR analyses were utilized to investigate the BRF2 expression status in tissues RESULTS: A notably higher level of BRF2 expression was found in NSCLC tissues at protein levels. In addition, univariate and multivariate analysis demonstrated that BRF2 protein over-expression and high MVD were significantly associated with tumor relapse. Although BRF2 overexpression and high MVD indicated poor 5-year overall survival (p = 0.004 and p = 0.019, respectively), multivariate analysis demonstrated that only BRF2 overexpression was an independent prognostic factor for unfavorable overall survival (P = 0.021). CONCLUSIONS: BRF2 is a promising biomarker to identify individuals with poor prognostic potential and a possible target for anti-angiogenic therapy for patients with early-stage NSCLC. |
format | Online Article Text |
id | pubmed-3921153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-39211532014-02-12 TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis Lu, Ming Tian, Hui Yue, Weiming Li, Lin Li, Shuhai Qi, Lei Hu, Wensi Gao, Cun Si, Libo PLoS One Research Article BACKGROUND: The aim of this study was to examine BRF2 expression in patients with non-small cell lung cancer (NSCLC) and explore the relationship of BRF2 protein with clinicopathologic factors, tumor angiogenesis and prognosis. METHODS: Both BRF2 protein and intratumoral microvessels were examined by immunohistochemical staining in 107 non-small cell lung cancer patients. Intratumoral m icrovessel density (MVD) was measured by counting CD-34 positive immunostained endothelial cells. Western blot and RT-PCR analyses were utilized to investigate the BRF2 expression status in tissues RESULTS: A notably higher level of BRF2 expression was found in NSCLC tissues at protein levels. In addition, univariate and multivariate analysis demonstrated that BRF2 protein over-expression and high MVD were significantly associated with tumor relapse. Although BRF2 overexpression and high MVD indicated poor 5-year overall survival (p = 0.004 and p = 0.019, respectively), multivariate analysis demonstrated that only BRF2 overexpression was an independent prognostic factor for unfavorable overall survival (P = 0.021). CONCLUSIONS: BRF2 is a promising biomarker to identify individuals with poor prognostic potential and a possible target for anti-angiogenic therapy for patients with early-stage NSCLC. Public Library of Science 2014-02-11 /pmc/articles/PMC3921153/ /pubmed/24523874 http://dx.doi.org/10.1371/journal.pone.0088032 Text en © 2014 Lu et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Lu, Ming Tian, Hui Yue, Weiming Li, Lin Li, Shuhai Qi, Lei Hu, Wensi Gao, Cun Si, Libo TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis |
title | TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis |
title_full | TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis |
title_fullStr | TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis |
title_full_unstemmed | TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis |
title_short | TFIIB-Related Factor 2 Over Expression Is a Prognosis Marker for Early-Stage Non-Small Cell Lung Cancer Correlated with Tumor Angiogenesis |
title_sort | tfiib-related factor 2 over expression is a prognosis marker for early-stage non-small cell lung cancer correlated with tumor angiogenesis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921153/ https://www.ncbi.nlm.nih.gov/pubmed/24523874 http://dx.doi.org/10.1371/journal.pone.0088032 |
work_keys_str_mv | AT luming tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT tianhui tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT yueweiming tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT lilin tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT lishuhai tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT qilei tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT huwensi tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT gaocun tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis AT silibo tfiibrelatedfactor2overexpressionisaprognosismarkerforearlystagenonsmallcelllungcancercorrelatedwithtumorangiogenesis |